Drugs that contain Saxagliptin Hydrochloride

1. Drug name - ONGLYZA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE44186 ASTRAZENECA AB Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
Jul, 2023

(7 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7951400 ASTRAZENECA AB Coated tablet formulation and method
Nov, 2028

(5 years from now)

Market Authorisation Date: 31 July, 2009

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 2.5MG BASE TABLET;ORAL Prescription
EQ 5MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.